- Pharmaceutical scientists working in process development and process optimization
- Pharmaceutical scientists in method development at all stages of the pharmaceutical development pipeline
- Anyone working on crystallization optimization
- Understand how to detect even the slightest changes that can put the performance of your drug substance at risk
- Discover easy to use techniques for solid form validation and impurities detection
- Learn what experimental approach is best for each solid form challenge (preferred orientation, sample fluorescence, polymorphic impurities)
Detect and control polymorphism: pro tips for pharmaceutical scientists
October 22, 2024 | 16:30 - 17:30 CET | Virtual
About The Event
Are you working on drug substance crystallization or optimizing crystallization processes? Success depends on delivering the right polymorph and detecting crystalline contaminations at low concentrations. Join us to discover the tools and techniques that simplify polymorph detection for teams working on the scale-up and production of pharmaceutical APIs. Our characterization experts will break down the power of the latest technology to show you how to embrace the power of XRD with confidence, whether you are an X-ray Diffraction (XRD) expert or don’t have a background in crystallography. Join us to: • Dive into relevant case studies of XRD analysis for API scale-up and process development • Discover how to identify even the most subtle changes that could jeopardize the performance of your drug substance • Discover easy-to-use techniques for solid form validation and impurities detection: we’ll show you Aeris and 1Der • Learn what experimental approach is best for each solid form challenge Products we’ll explore: Aeris, a compact XRD system designed to make solid-state analysis simple and efficient. Its plug-and-play simplicity makes it accessible to even non-crystallographers. Aeris delivers fast, high-quality data—providing a full pattern within five minutes—with exceptional sensitivity for detecting low concentrations. 1Der, the high energy resolution detector improves detection limits for polymorphic contaminants, while eliminating background interference from fluorescent elements like iron and lanthanum often found in drug substances.
More Information
Who should attend?
What will you learn?
About the API Scale-up Case Studies series
This is the first in our API Scale-up Case Studies series of webinars. Stay tuned as we take you on a journey revealing different challenges of small molecule pharmaceuticals API and Process Development. We will show you how to develop fast and robust methods for each analytical technology, what are typical pitfalls and how to avoid them.